Interim results of phase 2A study of VX-770 to evaluate safety, pharmacokinetics, and biomarkers of CFTR activity in cystic fibrosis subjects with G551D [abstract] - Accurso,F.J.; Rowe,S.M.; Durie,P. (Pediatr Pulmonol Suppl, 2008)